Preliminary proxy statement
Open the filing on sec.gov
Profusa, Inc. (PFSA)
Nasdaq: PFSA · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2021
The companyfiscal 2024, as filed
Revenue$100,000
Net income-$9.2M-894.4%
Earnings per share$-357.14-297716.7%
Operating cash flow-$2.1M-0.1%
Cash$191,000+34.5%
Debtn/a
Shareholders’ equity-$119M-8.4%
Shares, diluted25,844-99.5%
Return on equityn/a
The recordfrom its filings
Filings in 2026102
Newest filingNov 10 · PRE 14A
Annual reportApr 15, 2026
Quarterly reportAug 19, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted26
Filer category<br>Emerging growth company
Trailing twelve months to Jun 2026Net income -$43.0MCash from operations -$20.3Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Current report
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Current report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.